INTU vs. GMED

Last updated Jul 11, 2026

INTU (Intuit Inc.) and GMED (Globus Medical, Inc.) are both stocks. INTU operates in Software - Application (Technology), while GMED operates in Medical Devices (Healthcare). Over the past 10 years, INTU returned 9.85%/yr vs 12.07%/yr for GMED. At a 0.34 correlation, their price movements are largely independent.

Performance

INTU vs. GMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Intuit Inc. (INTU) and Globus Medical, Inc. (GMED). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, INTU achieves a -58.10% return, which is significantly lower than GMED's -10.54% return. Over the past 10 years, INTU has underperformed GMED with an annualized return of 9.85%, while GMED has yielded a comparatively higher 12.07% annualized return.

INTU

• 1D: 0.58%
• 1M: -0.26%
• 6M: -57.18%
• YTD: -58.10%
• 1Y: -62.82%
• 3Y*: -15.32%
• 5Y*: -10.76%
• 10Y*: 9.85%

GMED

• 1D: 1.92%
• 1M: -2.99%
• 6M: -17.32%
• YTD: -10.54%
• 1Y: 36.75%
• 3Y*: 8.91%
• 5Y*: -0.63%
• 10Y*: 12.07%

*Multi-year figures are annualized to reflect compound growth (CAGR)

INTU vs. GMED - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
INTU Intuit Inc.	-58.10%	6.09%	1.16%	61.76%	-39.12%	70.27%	46.12%	34.11%	25.86%	39.21%
GMED Globus Medical, Inc.	-10.54%	5.56%	55.21%	-28.25%	2.87%	10.70%	10.77%	36.04%	5.30%	65.66%

Correlation

The correlation between INTU and GMED is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.09
Correlation (3Y) Calculated over the trailing 3-year period	0.25
Correlation (5Y) Calculated over the trailing 5-year period	0.35
Correlation (10Y) Calculated over the trailing 10-year period	0.37
Correlation (All Time) Calculated using the full available price history since Aug 3, 2012	0.34

Over the past year, the correlation between INTU and GMED has dropped to 0.09 - well below their long-term average of 0.34, suggesting their price drivers have been diverging.

Fundamentals

Market Cap INTU : $75.21B GMED : $10.53B
EPS INTU : $16.37 GMED : $4.28
PE Ratio INTU : 16.80 GMED : 18.23
PEG Ratio INTU : 1.00 GMED : 0.19
PS Ratio INTU : 3.68 GMED : 3.45
PB Ratio INTU : 3.68 GMED : 2.28
Total Revenue (TTM) INTU : $20.93B GMED : $3.10B
Gross Profit (TTM) INTU : $16.97B GMED : $1.58B
EBITDA (TTM) INTU : $6.65B GMED : $803.34M

Return for Risk

INTU vs. GMED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INTU

INTU Risk / Return Rank: 3
INTU Sharpe Ratio Rank: 1
INTU Sortino Ratio Rank: 2
INTU Omega Ratio Rank: 2
INTU Calmar Ratio Rank: 6
INTU Martin Ratio Rank: 4

GMED

GMED Risk / Return Rank: 73
GMED Sharpe Ratio Rank: 69
GMED Sortino Ratio Rank: 75
GMED Omega Ratio Rank: 72
GMED Calmar Ratio Rank: 75
GMED Martin Ratio Rank: 75

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INTU vs. GMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Intuit Inc. (INTU) and Globus Medical, Inc. (GMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	INTU	GMED	Difference
Sharpe ratio: Return per unit of total volatility	-1.39	0.71	-2.10
Sortino ratio: Return per unit of downside risk	-2.32	1.75	-4.07
Omega ratio: Gain probability vs. loss probability	0.70	1.21	-0.51
Calmar ratio: Return relative to maximum drawdown	-0.92	1.60	-2.52
Martin ratio: Return relative to average drawdown	-1.64	3.87	-5.51

INTU vs. GMED - Sharpe Ratio Comparison

The current INTU Sharpe Ratio is -1.39, which is lower than the GMED Sharpe Ratio of 0.71. The chart below compares the historical Sharpe Ratios of INTU and GMED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

INTU vs. GMED - Drawdown Comparison

The maximum INTU drawdown since its inception was -75.29%, which is greater than GMED's maximum drawdown of -47.91%. Use the drawdown chart below to compare losses from any high point for INTU and GMED.

Drawdown Indicators

	INTU	GMED	Difference
Max Drawdown Largest peak-to-trough decline	-75.29%	-47.91%	-27.38%
Max Drawdown (1Y) Largest decline over 1 year	-68.19%	-22.10%	-46.09%
Max Drawdown (3Y) Largest decline over 3 years	-68.19%	-44.40%	-23.79%
Max Drawdown (5Y) Largest decline over 5 years	-68.19%	-47.91%	-20.28%
Max Drawdown (10Y) Largest decline over 10 years	-68.19%	-47.91%	-20.28%
Current Drawdown Current decline from peak	-65.56%	-19.32%	-46.24%
Average Drawdown Average peak-to-trough decline	-24.23%	-15.33%	-8.90%
Ulcer Index Depth and duration of drawdowns from previous peaks	38.28%	9.13%	+29.15%

Volatility

INTU vs. GMED - Volatility Comparison

The current volatility for Intuit Inc. (INTU) is 11.58%, while Globus Medical, Inc. (GMED) has a volatility of 13.69%. This indicates that INTU experiences smaller price fluctuations and is considered to be less risky than GMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	INTU	GMED	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.58%	13.69%	-2.11%
Volatility (6M) Calculated over the trailing 6-month period	43.23%	25.33%	+17.90%
Volatility (1Y) Calculated over the trailing 1-year period	45.43%	49.46%	-4.03%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	37.82%	38.27%	-0.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	34.09%	35.68%	-1.59%

Dividends

INTU vs. GMED - Dividend Comparison

INTU's dividend yield for the trailing twelve months is around 1.75%, while GMED has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
GMED Globus Medical, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
INTU Intuit Inc.	1.75%	0.65%	0.60%	0.52%	0.72%	0.38%	0.57%	0.74%	0.83%	0.89%	1.08%	1.09%

Financials

INTU vs. GMED - Profitability Comparison

The chart below illustrates the profitability comparison between Intuit Inc. and Globus Medical, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

INTU - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Intuit Inc. reported a gross profit of 7.24B and revenue of 8.56B. Therefore, the gross margin over that period was 84.6%.

GMED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.

INTU - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Intuit Inc. reported an operating income of 4.02B and revenue of 8.56B, resulting in an operating margin of 47.0%.

GMED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.

INTU - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Intuit Inc. reported a net income of 3.06B and revenue of 8.56B, resulting in a net margin of 35.8%.

GMED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.

Frequently Asked Questions

Can I hold both INTU and GMED in my portfolio?

INTU and GMED have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, INTU or GMED?

GMED has higher volatility (13.69%) compared to INTU (11.58%). In terms of maximum drawdown, INTU dropped -75.29% vs GMED's -47.91%.

Which has better risk-adjusted returns?

GMED currently has the higher Sharpe Ratio (0.71 vs -1.39), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.